Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Geographical distribution, a risk factor for the incidence of lupus nephritis in China

Authors: Qingjun Pan, Yaning Li, Ling Ye, Zhenzhen Deng, Lu Li, Yongmin Feng, Weijing Liu, Huafeng Liu

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Geographical variation in lupus nephritis epidemiology may indicate important environmental factors contributions to the etiology of lupus nephritis. This paper first describes the epidemiology of biopsy-proven lupus nephritis in China by performing a systematic literature review and the possible social-environmental influential factors.

Methods

The keywords “lupus nephritis”, “renal biopsy” and “systemic lupus erythematous” were searched in the three largest Chinese electronic databases and Medline/PubMed. The data of the patients with biopsy-proven lupus nephritis were extracted. The possible environmental influential factors including the population density, ethnic group populations, the ratio of females to males, the average sunshine per year, annual average temperature and annual relative humidity, in different regions of China were analyzed.

Results

Forty-one study centers with 34574 renal disease patients, and 3699 lupus nephritis patients met the inclusion criteria. Lupus nephritis accounts for 2.37% to 25% of all renal disease and 27.2% to 80.65% of renal disease associated with secondary glomerular diseases. The male-to-female ratio is approximately 1:5 in lupus nephritis patients. The included period is predominantly from 1995 to 2010. The proportion ratio of biopsy-proven lupus nephritis in all renal disease or in secondary glomerular disease significantly increased with decreasing latitude from the north to the south part of China. The population is predominantly Han Chinese.

Conclusions

Geographical distribution appears to be a risk factor for the incidence of biopsy-proven LN in China.
Appendix
Available only for authorised users
Literature
1.
Rahman A, Isenberg DA: Systemic lupus erythematosus. N Engl J Med. 2008, 358 (9): 929-939. 10.1056/NEJMra071297.CrossRefPubMed
2.
Vasudevan A, Krishnamurthy AN: Changing worldwide epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am. 2010, 36 (1): 1-13. 10.1016/j.rdc.2009.12.005.CrossRefPubMed
3.
Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME: The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev. 2010, 9 (5): 277-287. 10.1016/j.autrev.2009.12.008.CrossRef
4.
Tikly M, Navarra SV: Lupus in the developing world–is it any different?. Best Pract Res Clin Rheumatol. 2008, 22 (4): 643-655. 10.1016/j.berh.2008.05.003.CrossRefPubMed
5.
Austin HA: Clinical evaluation and monitoring of lupus kidney disease. Lupus. 1998, 7 (9): 618-621. 10.1191/096120398678920749.CrossRefPubMed
6.
Patel M, Clarke AM, Bruce IN, Symmons DP: The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum. 2006, 54 (9): 2963-2969. 10.1002/art.22079.CrossRefPubMed
7.
Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN: Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010, 19 (5): 557-574. 10.1177/0961203309358187.CrossRefPubMed
8.
Bastian HM, Roseman JM, McGwin G, Alarcón GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD, LUMINA Study Group. LUpus in MInority populations: NAture vs nurture: Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002, 11 (3): 152-160. 10.1191/0961203302lu158oa.CrossRefPubMed
9.
Seligman VA, Lum RF, Olson JL, Li H, Criswell LA: Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med. 2002, 112 (9): 726-729. 10.1016/S0002-9343(02)01118-X.CrossRefPubMed
10.
Kim I, Kim YJ, Kim K, Kang C, Choi CB, Sung YK: Genetic studies of systemic lupus erythematosus in Asia: where are we now?. Genes Immun. 2009, 10 (5): 421-432. 10.1038/gene.2009.24.CrossRefPubMed
11.
Adler M, Chambers S, Edwards C, Neild G, Isenberg D: An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology. 2006, 45 (9): 1144-1147. 10.1093/rheumatology/kel039.CrossRefPubMed
12.
Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B: Outcomes in African-Americans and Hispanics with Lupus Nephritis. Kidney Int. 2006, 69 (10): 1846-1851. 10.1038/sj.ki.5000243.CrossRefPubMed
13.
Korbet SM, Schwartz MM, Evans J, Lewis EJ, Collaborative Study Group: Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol. 2007, 18 (1): 244-254. 10.1681/ASN.2006090992.CrossRefPubMed
14.
Austin HA, Boumpas DT, Vaughan EM, Balow JE: High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant. 1995, 10 (9): 1620-1628.PubMed
15.
16.
Churg J, Sobin LH: Renal Disease: Classification and Atlas of Glomerular Disease. 1982, Tokyo: Igaku-Shoin
17.
Churg J, Bernstein J, Glassock RJ: Renal Disease: Classification and Atlas of Glomerular Diseases. 1995, New York: Igaky-Shoin, 2
18.
Xu YZ, Tan DS, Liu HF, Lin HP, Liang D, Huang ZQ: Clinicopathological analysis on 1672 biopsies of glomerular diseases. J Guangdong Med Coll. 2009, 27: 377-379. (in Chinese)
19.
Luo Q, Xiong ZB, Xiong ZY, Wang Q, Zhang Y, Hou S, et al: Clinicopathological analysis on 615 cases of renal biopsy of adult people. Chin J Integr Tradit West Nephrol. 2008, 9: 531-(in Chinese)
20.
Mo WG, Zeng JJ, Feng ZB, Liao YJ: Analysis of the prevalence and pathological types of 1499 cases of biopsy-proven kidney disease. J Guangxi Med Univ. 2004, 21: 850-853. (in Chinese)
21.
Zhong HB, Huang S, Yu YH, Yang SX, Liao AN, Wang XH: Clinical and pathological features of 913 cases remote mail renal biopsy data. Chin J Integr Trad Wes Nephrol. 2007, 8: 154-156. (in Chinese)
22.
Chen JY, Yuan ZY: Clinicopathological analysis of 269 Renal Biopsies. Mod Med Health. 2008, 24: 2012-2013. (in Chinese)
23.
Zhu CL, Chen YF, Peng HY, Gong Y: Signification of clinicopathological analysis on 100 biopsies of nephritic diseases. Guizhou Med J. 2003, 27: 345-347. (in Chinese)
24.
Li SR, Jiang QH, Chen CS, Hu XM, Shao GJ: Analysis of 113 renal biopsies. Jiangxi Med J. 2004, 39: 197-198. (in Chinese)
25.
Ke YJ, Wu GH, Li YS, Chen YJ, Yang JP, Chen XL, Dai ZY, Gao XF: Clinicopathological analysis of 113 renal biopsies. Chin J Integr Trad Wes Nephrol. 2004, 5: 546-547. (in Chinese)
26.
Xiang XQ, Xia YC, Liu YH, Peng YM, Jiang WL, Li J: Comparative analysis of pathology and clinic on 1211 cases of renal biopsy of adult people. J Cent South Univ Technol. 2005, 30: 733-735. in Chinese
27.
Sun T, Zhao HW, Wu XF, Wang DZ, Li L: Clinical pathological analysis of 489 renal biopsies. Chongqing Med J. 2006, 35: 934-937. (in Chinese)
28.
Shi XD, Chen SF, Hu XQ, Fan DY: Pathological analysis of 669 renal biopsies. Zhejiang Clin Med J. 2003, 5: 724-725. (in Chinese)
29.
Xu YC, Yang Q, Dong DD, Li K: Pathological analysis of 140 renal biopsies. Sichuan Med J. 2005, 26: 629-631. (in Chinese)
30.
Liu K, Chen XY: Analysis of 107 renal biopsies. Appl J Gen Pract. 2007, 5: 384-
31.
Yu JP, Yang XY, Cui RL, Yuan WJ: Clinical analysis of 177 percutaneous renal biopsies. Acad J Sec Mil Med univ. 2000, 21: 800-in Chinese
32.
Chen HP, Zeng CH, Hu WX, Wang QW, Yu YS, Yao XD, Tang Z, Wang JP, Zhu MY, Zhou H, Liu H, Liu ZH, Li LS: Analysis of 10594 renal biopsies data. Chin J Nephrol Dial Transpl. 2000, 9: 501-509. (in Chinese)
33.
Peng YP, Li J, Liu ZW, Yin ST: Clinicopathological analysis on 176 renal biopsies. Anhui Med J. 2005, 26: 531-532. (in Chinese)
34.
Wang T, Liu DG, Shen JQ, Zhou JD: Analysis on cinical pathological data of 805 cases undergoing renal biopsy in part of Jiangsu province. J Southeast Univ (Med Sci). 2010, 29: 301-305. (in Chinese)
35.
Fan YL, Zhong LM, Lv YX, Wang XL, Meng XH: Clinical application and complications of renal biopsy. Anhui Med J. 1995, 16: 14-(in Chinese)
36.
Du JL, Wang HM, Yu Y, Lian YG, Chen W, Zhang J, Liu YF: Analysis on clinicopathological data of 1542 cases undergoing renal biopsies. Acad J Fourth Mil Med Univ. 2006, 27: 1599-1602. (in Chinese)
37.
Shi J, Liu JH, Tian G: Clinical pathological analysis of 253 renal biopsies. J Pract Med Tech. 2010, 17: 775-776. (in Chinese)
38.
Wang HX, Chen MJ, Wang XY, Wu L: Clinical pathological analysis of 352 renal biopsies. J Chin Phys. 2007, 9: 1699-(in Chinese)
39.
Li SK, Yin ZC, Dai C, Li FC, Zhou SD, Zhang XB, Jin YL: Clinical pathological analysis of 743 renal biopsies. Acta Acad Med Zunyi. 2009, 32: 473-475. (in Chinese)
40.
Wang YT, Xu QY, Guo MH, Zhu TC: Analysis of the prevalence of 919 cases of renal biopsy. Chin J Inte Trad Wes Nephrol. 2010, 11: 232-234. (in Chinese)
41.
Zhao ZZ, Zheng CH, Xiao J, Liu ZS: Clinicopathological analysis on 412 renal biopsies. J Zhengzhou Univ (Med Sci). 2005, 40: 368-369.
42.
Li XY, Xie QK: Clinicopathological analysis on 144 renal biopsies. Chin Med Eng. 2007, 15: 735-737. (in Chinese)
43.
Zhou SY, Tang XP, Zhang PY, Yue XH, Wang YL: Analysis on 1202 renal biopsies in Ultrastructural pathological diagnosis. J Nat Defending Forces Med Southwest Chin. 2008, 29: 60-(in Chinese)
44.
Zheng CX, Duan LP, Hao HY, Xu L, Liu YF: Clinicopathological analysis on 469 renal biopsies in Handan Area. J Clin Nephrol. 2009, 9: 74-75. (in Chinese)
45.
Huo J, Li RS: Characteristics of the prevalence and pathological data of 1281 cases of renal biopsy in Shanxi Province. Chin J Nephrol. 2007, 23: 675-676. (in Chinese)
46.
Wang YM, Liu ZQ: Analysis of 268 clinical cases of renal biopsy. Med Res Educ. 2010, 27: 39-40. (in Chinese)
47.
Zhao CX, Jia LM, Guo TB, Du ST: Clinicopathological analysis on 190 renal biopsies. Mod J Integrated Tradit Chin Western Med. 2009, 18: 3610-(in Chinese)
48.
Ding XG, Li XD, Gao SL, Guo ZJ: Clinicopathological analysis on 362 renal biopsies. Chin J Mod Med. 2008, 18: 1905-1909. (in Chinese)
49.
Zhang YP, Chen XM, Wu D, Chen QS: Analysis of the prevalence and pathological types of 1954 cases of biopsy-proven kidney disease. J Clin Nephrol. 2001, 1: 53-59. (in Chinese)
50.
Wang WX, Zhang L, Zhou W, Shi HB: Clinical pathological analysis of 104 renal biopsies. J Clin Med. 1996, 16: 1-3. (in Chinese)
51.
Liu WX: Analysis on clinicopathological data of 100 cases undergoing renal biopsy. World Health Digest. 2008, 5: 572-574. (in Chinese)
52.
Hou XY, Meng YP, Zhao JR: Clinicopathological analysis on 217 renal biopsies in Nei Menggu area. Chin J Integrated Tradit Wes Nephrol. 2009, 10: 1071-(in Chinese)
53.
Wang CH, Yang LH, Ma F, Liu SY, Zhao JM: Composition analysis of 262 renal biopsies of kidney disease. J Clin Nephrol. 2009, 9: 76-(in Chinese)
54.
Li YQ, Wang Y, Li XL, Yao L, Feng JM, Ma JF, Zhang YX, Wang LN: Analysis of 1259 renal biopsy data in Liaoning area. Chin J Mod Med. 2006, 16: 2830-2833. (in Chinese)
55.
Feng W, Liang LQ, Liu Y, Lie CH: Aziguli: pathological analysis of 1500 renal biopsies. J Clin Nephrolo. 2008, 8 (11): 505-507. (in Chinese)
56.
Yue H, Zhou J, Adila , He W, Qiao LP, Alinuer , Liu J, Sang XH: Analysis on pathologic data and clinical characteristics of renal biopsy in Uyghur and Han nationalities. Xinjiang Med J. 2006, 36: 1-3. (in Chinese)
57.
Wang LY, Liu SJ, Tian Y: Pathological analysis of 500 renal biopsies. Chin J Lab Diagn. 2005, 9: 20-21. (in Chinese)
58.
Jiang GT, Zhang QQ, An HX, Liu SY: Analysis on pathologic data and clinical characteristics of renal biopsy in Heilongjiang. Hei Longjiang Med J. 2008, 32: 423-(in Chinese)
59.
Nossent JC: Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation. Ann Rheum Dis. 1992, 51 (11): 1197-1201. 10.1136/ard.51.11.1197.CrossRefPubMedPubMedCentral
60.
Al-Maini MH, El-Ageb EM, Al-Wahaibi SS, Al-Farsi Y, Richens ER: Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol In. 2003, 23 (4): 186-191. 10.1007/s00296-003-0303-6.CrossRef
61.
Villamin CA, Navarra SV: Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol. 2008, 18 (2): 161-164. 10.3109/s10165-008-0029-0.CrossRefPubMed
62.
Haiyan W: Nephrology. 2008, Beijing: People's Medical Publishing House, 1321-1342. Third
63.
Houssiau FA: Management of lupus nephritis: an update. J Am Soc Nephrol. 2004, 15 (10): 2694-2704. 10.1097/01.ASN.0000140218.77174.0A.CrossRefPubMed
64.
Bo H, Yuesi W, Guangren L: Variation characteristics of ultraviolet radiation derived from measurement and reconstruction in Beijing, China. Tellus. 2010, 62B: 100-108.
65.
Ke W, Wen C, Ronghui H: Long-term changes of the ultraviolet radiation in China and its relationship with total ozone and precipitation. Adv Atmos Sci. 2006, 23 (5): 700-710. 10.1007/s00376-006-0700-3.CrossRef
66.
Huali Z, Shilhao X, Delhen T, Dong L, Huafeng L: Seasonal distribution of active systemic lupus erythematosus and its correlation with meteorological factors. Clinic. 2011, 66 (6): 1009-1013.CrossRef
Metadata
Title
Geographical distribution, a risk factor for the incidence of lupus nephritis in China
Authors
Qingjun Pan
Yaning Li
Ling Ye
Zhenzhen Deng
Lu Li
Yongmin Feng
Weijing Liu
Huafeng Liu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-67

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue

Research article

Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study

Research article

Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis

Research article

Health care provider perception of chronic kidney disease: knowledge and behavior among African American patients

Research article

Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function

Research article

Whole exome sequencing reveals novel COL4A3 and COL4A4mutations and resolves diagnosis in Chinese families with kidney disease

Research article

Understanding physicians’ behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits